Molecular Insight into the Inhibitory Mechanism of Galangin Towards Human Cytochrome P450 1A2. A Modeling Study

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|8|3|216-222

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.3, 2011-03, pp. : 216-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Interactions Between Human Cytochrome P450 1A2 and Flavone Derivatives

By  

Medicinal Chemistry, Vol. 2, Iss. 4, 2006-07 ,pp. : 401-406

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling of Cytochrome P450 and Drug Metabolism

By  

Current Drug Metabolism, Vol. 11, Iss. 4, 2010-05 ,pp. : 342-346

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2

By  

Current Drug Metabolism, Vol. 10, Iss. 7, 2009-09 ,pp. : 713-729

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D

By Delaforge M.   Jaouen M.   Bouille G.  

Environmental Toxicology and Pharmacology, Vol. 7, Iss. 3, 1999-07 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite

Stereoselectivity of Human Cytochrome P450 in Metabolic and Inhibitory Activities

By  

Current Drug Metabolism, Vol. 12, Iss. 6, 2011-07 ,pp. : 549-569

Bentham Science Publishers

Access to resources Recommend Favorite